A Randomized Multicentre Trial to Evaluate the Utilization of Revascularization or Optimal Medical Therapy for the Treatment of Chronic Total Coronary Occlusions
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 450 participants.
Also called NCT01760083
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 450 participants
- Sponsor
- Registry
-
NCT01760083
-
- Main results
- A randomized multicentre trial to compare revascularization with optimal medical therapy for the treatment of chronic total coronary occlusions
- Other papers using this trial's data
- Three-year outcomes of A Randomized Multicentre Trial Comparing Revascularization and Optimal Medical Therapy for Chronic Total Coronary Occlusions (EuroCTO)
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- France, Germany, Italy, Latvia, Spain, United Kingdom
- Registry status
- Completed
Technical summary
Registry record NCT01760083. Randomized; no masking; primary purpose treatment. Start 2013-01 (actual); primary completion 2016-05 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Randomized Multicentre Trial to Evaluate the Utilization of Revascularization or Optimal Medical Therapy for the Treatment of Chronic Total Coronary Occlusions
- Acronym
- EuroCTO
- Condition
- Chronic Stable Angina
- Condition
- Dyspnea
- Condition
- Coronary Occlusion
- Intervention (Device)
- Biolimus-eluting stent implantation
- Lead sponsor
- Euro CTO Club
- Collaborator
- NHS Research and Development
- Collaborator
- Biosensors International
- Collaborator
- Asahi Intecc Co., Ltd.
Record details
- Record id
cardio:ct-nct01760083- Content hash
6bf127e74465a56d44e80832e8ad61128ca0993e12624b0286db7764135c6d99